INTERCEPT PHARMACEUTICALS, INC. short interest in 2019
In 2019, INTERCEPT PHARMACEUTICALS, INC.'s disclosed short interest ran from 10.29% of shares outstanding on 15 Jan 2019 to 13.82% on 31 Dec 2019, a change of +3.53 percentage points. The year's high was 19.16% on 28 Jun 2019 and its low 9.61% on 31 Jan 2019, averaging 15.97% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.44 days on 31 Oct 2019. Full history: INTERCEPT PHARMACEUTICALS, INC..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023
2019 in figures
- Start of year
- 10.29% (15 Jan 2019)
- End of year
- 13.82% (31 Dec 2019)
- Change
- +3.53 pp
- High
- 19.16% (28 Jun 2019)
- Low
- 9.61% (31 Jan 2019)
- Average
- 15.97%
- Highest days to cover
- 13.44 (31 Oct 2019)
- SEC filings marked
- 8
Every report in 2019
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2019 | 10.29% | 6.01 | |
| 31 Jan 2019 | 9.61% | 5.10 | |
| 15 Feb 2019 | 10.89% | 4.67 | |
| 28 Feb 2019 | 16.51% | 1.54 | results (8-K) |
| 15 Mar 2019 | 15.53% | 5.18 | 10-K filed |
| 29 Mar 2019 | 14.83% | 8.32 | |
| 15 Apr 2019 | 15.98% | 3.77 | |
| 30 Apr 2019 | 17.65% | 5.80 | |
| 15 May 2019 | 18.38% | 5.63 | 10-Q filed, results (8-K) |
| 31 May 2019 | 17.99% | 11.08 | |
| 14 Jun 2019 | 18.25% | 7.45 | |
| 28 Jun 2019 | 19.16% | 11.19 | |
| 15 Jul 2019 | 17.79% | 8.64 | |
| 31 Jul 2019 | 15.61% | 7.80 | |
| 15 Aug 2019 | 15.79% | 8.53 | results (8-K), 10-Q filed |
| 30 Aug 2019 | 16.18% | 11.92 | |
| 13 Sep 2019 | 16.59% | 10.92 | |
| 30 Sep 2019 | 17.49% | 11.72 | |
| 15 Oct 2019 | 17.41% | 10.63 | |
| 31 Oct 2019 | 17.24% | 13.44 | |
| 15 Nov 2019 | 17.47% | 10.87 | 10-Q filed, results (8-K) |
| 29 Nov 2019 | 16.66% | 7.08 | |
| 13 Dec 2019 | 16.05% | 5.66 | |
| 31 Dec 2019 | 13.82% | 8.16 |
See also: INTERCEPT PHARMACEUTICALS, INC.'s full history · most shorted US stocks of 2019 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.